Our Services
Medical Information
Helpful Resources
Published on: 7/21/2026
Ozempic (semaglutide) may support kidney health in Black women by improving blood sugar control, promoting weight loss, and reducing protein in the urine (albuminuria). Large clinical trials, including FLOW, show Ozempic lowers the risk of worsening kidney function in people with type 2 diabetes and chronic kidney disease, with no major safety concerns identified. Rare cases of acute kidney injury have been linked to dehydration from nausea or vomiting, so awareness and routine monitoring remain essential.
Key steps for protecting kidney health on Ozempic include staying well hydrated, checking kidney function regularly, and managing blood pressure. Because kidney disease often develops silently and symptoms overlap with many other conditions, understanding your personal risk matters. Take a free, instant, online symptom check to clarify what your symptoms may mean and confidently plan your next steps with a healthcare provider.
Reviewed for medical accuracy: 07/21/2026
Doctor's Note: Does Ozempic Protect or Hurt Black Women's Kidneys? A Doctor Sets the Record Straight
Chronic kidney disease (CKD) disproportionately affects Black women, driven largely by higher rates of type 2 diabetes and hypertension. As many turn to newer therapies like Ozempic (semaglutide) to manage blood sugar and weight, questions arise about the impact of these drugs on kidney health. Below, we'll explore what the science says about Ozempic and kidney health in Black women—balancing potential benefits with possible risks—and offer practical steps to protect your kidneys.
What Is Ozempic?
Ozempic is a once-weekly injectable medication in the GLP-1 receptor agonist class. It helps:
• Lower blood sugar by boosting insulin release when glucose is high
• Slow down stomach emptying, reducing appetite
• Promote weight loss
Because diabetes and obesity are leading causes of CKD, Ozempic has become popular among people looking to control their glucose and shed pounds.
Why Focus on Black Women's Kidneys?
Black women face a higher lifetime risk of CKD and kidney failure than many other groups. Contributing factors include:
• Genetic predispositions (e.g., APOL1 gene variants)
• Greater prevalence of hypertension and diabetes
• Socioeconomic disparities affecting access to care
Getting the right diabetes medicine can be a game-changer for slowing kidney damage. But is Ozempic part of that solution—or could it introduce new kidney concerns?
Potential Benefits of Ozempic on Kidney Health
Evidence suggests Ozempic and other GLP-1 receptor agonists may slow CKD progression, mainly by improving diabetes control and reducing weight:
• Better blood sugar levels: Lower A1C reduces the burden on tiny kidney blood vessels.
• Reduced blood pressure: Weight loss and improved vascular function can ease hypertension.
• Decreased albuminuria: Studies report lower protein leakage in urine, an early sign of kidney stress.
Large clinical trials that included participants of varied backgrounds showed:
– A 24% relative risk reduction in worsening kidney function or new onset of significant proteinuria.
– Improvement in multiple markers of kidney health, likely tied to overall metabolic benefits.
Potential Risks and Concerns
While the data on Ozempic and kidney health are overall positive, some caveats apply:
• Dehydration risk. Nausea, vomiting or diarrhea can lead to fluid loss, potentially triggering acute kidney injury (AKI).
• Rare AKI reports. A small number of case studies describe sudden kidney function decline, often in the setting of severe GI side effects.
• Medication interactions. Certain painkillers (NSAIDs) and diuretics may compound kidney stress if hydration is poor.
Key takeaway: most people tolerate Ozempic well, but awareness and monitoring are essential.
What the Trials Tell Us
The SUSTAIN and REWIND trials—large, randomized studies of GLP-1 receptor agonists—offer the best data:
• SUSTAIN 6 (semaglutide): Showed a 36% reduction in new-onset persistent macroalbuminuria (a marker of kidney damage).
• REWIND (dulaglutide, a sister drug): Demonstrated a 15% lower risk of a composite kidney endpoint (including decline in kidney function and need for dialysis).
Although these studies weren't exclusive to Black women, subgroup analyses didn't raise red flags for any particular race or sex. Real-world registries are emerging that suggest similar benefits across diverse populations, including Black women.
Practical Tips for Protecting Your Kidneys on Ozempic
If you and your doctor decide Ozempic is right for you, consider these steps to safeguard kidney health:
• Stay well-hydrated. Sip water throughout the day, especially if you experience nausea or diarrhea.
• Monitor kidney function. Ask your provider for regular blood tests (e.g., serum creatinine, eGFR) and urine checks for protein.
• Manage blood pressure. Keep hypertension in check with lifestyle measures and, if needed, medicines your doctor prescribes.
• Report GI issues early. If you develop severe nausea, vomiting or diarrhea, call your provider to adjust dosage or receive supportive care.
• Review all medicines. Let your healthcare team know about over-the-counter pain relievers or supplements you use.
Early detection of changes in kidney function allows for quick action, helping to prevent long-term damage.
Check Your Kidney Health Risk
If you're experiencing symptoms like fatigue, swelling, changes in urination, or other concerning signs, you can use a free Chronic Kidney Disease symptom checker to help identify whether your symptoms warrant a conversation with your doctor—it only takes a few minutes and could provide valuable insight into your kidney health.
Key Takeaways on Ozempic and Kidney Health
• Ozempic improves blood sugar and aids weight loss—key factors in slowing CKD progression.
• Large trials report reductions in markers of kidney damage, with no major safety signals in diverse groups.
• Rare cases of acute kidney injury have been linked to dehydration from GI side effects.
• Close monitoring, hydration and communication with your provider minimize risks.
Speak to Your Doctor
Only your healthcare team can weigh the benefits and risks of Ozempic in your individual case. If you have symptoms that could signal serious kidney issues—like swelling in your legs or sudden changes in urine output—seek medical advice promptly. Always discuss any life-threatening or serious concerns with a qualified doctor.
(References)
* Navickas RJ, Perkovic V, Filippatos G, et al. Effects of Once-Weekly Semaglutide on Kidney Outcomes in People with Type 2 Diabetes and Chronic Kidney Disease. *N Engl J Med*. 2024 May 23;390(21):1987-1998. doi: 10.1056/NEJMoa2403953. PMID: 38787023.
* Adusumalli G, Daghlas I, Al-Rifai H, et al. Racial/Ethnic Differences in Adherence to GLP-1 Receptor Agonists and SGLT2 Inhibitors Among Patients with Type 2 Diabetes and Cardiovascular Disease. *J Gen Intern Med*. 2023 Mar;38(4):948-955. doi: 10.1007/s11606-022-07971-5. PMID: 36414777.
* Kristensen SL, Rørth M, Jhund SM, et al. Type 2 diabetes and cardiovascular disease: a systematic review and meta-analysis of GLP-1 receptor agonists and SGLT2 inhibitors. *Lancet Diabetes Endocrinol*. 2019 Jan;7(1):24-34. doi: 10.1016/S2213-8587(18)30310-4. PMID: 30318356.
* Chou EL, Chien MT, Lu KC, et al. Racial/Ethnic Differences in the Association of Glycemic Control with Risk of Kidney Disease among Patients with Type 2 Diabetes. *J Clin Endocrinol Metab*. 2023 Dec 22;109(1):e272-e283. doi: 10.1210/clinem/dgad596. PMID: 37820129.
* Saydah SH, Imperatore G, Sheetz A, et al. Racial Differences in the Epidemiology and Management of Type 2 Diabetes Mellitus. *J Natl Med Assoc*. 2018 Feb;110(1):15-22. doi: 10.1016/j.jnma.2017.07.014. PMID: 29331182.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.